Compugen

Compugen Ltd. is a clinical-stage therapeutic discovery and development company headquartered in Holon, Israel. It specializes in the research, development, and commercialization of novel therapeutic candidates primarily in the field of cancer immunotherapy. The company's immuno-oncology pipeline includes several clinical-stage programs, such as COM701, an anti-PVRIG antibody, and COM902, which targets TIGIT, both designed for the treatment of solid tumors. Compugen employs advanced computational methods for drug discovery, utilizing in silico techniques to predict and select promising drug targets, followed by rigorous experimental validation. The company collaborates with major pharmaceutical partners, including Bayer Pharma AG and Bristol-Myers Squibb, to enhance its research and development efforts. Compugen's focus on innovative therapeutic solutions aims to address significant unmet medical needs in oncology, leveraging its unique predictive capabilities and a robust pipeline of early-stage programs targeting immune resistance mechanisms.

Ari Krashin

CFO, Finance and COO, Operations

4 past transactions

SynerSolutions Technologies

Acquisition in 2024
SynerSolutions Technologies is a specialized information technology company that focuses on providing advanced cybersecurity solutions to military, defense, and intelligence government agencies. The company leverages artificial intelligence, machine learning, and deep learning to develop pattern recognition and isolation technologies, along with quantum cryptography, to deliver cutting-edge cybersecurity strategies and architectures tailored to the unique needs of its clients.

CPU

Acquisition in 2023
CPU is a provider of comprehensive information technology services. They offer infrastructure management, technical support, product deployment, and professional services tailored to meet current and future technological needs. Additionally, they deliver advanced technology products and solutions, including network security, online storage, cloud services, and management consulting, enabling clients to optimize their IT infrastructure efficiently.

GlobalServe

Series F in 2013
GlobalServe, Inc. is a Valhalla, New York-based company that specializes in international information technology equipment supply chain services. Established in 1996, it serves as a single point of contact for organizations looking to manage their IT investments globally. The company offers a comprehensive suite of services, including procurement, deployment, operation, replacement, and recycling of IT equipment such as laptops, desktops, servers, and network devices. Additionally, GlobalServe provides a range of IT services, including hardware support, data backup and recovery, staff augmentation, and consulting. Its diverse client base spans industries such as oil and gas, manufacturing, consumer products, quick service restaurants, and technology. With an additional office in London, GlobalServe continues to enhance its global reach and service offerings.

GlobalServe

Series E in 2007
GlobalServe, Inc. is a Valhalla, New York-based company that specializes in international information technology equipment supply chain services. Established in 1996, it serves as a single point of contact for organizations looking to manage their IT investments globally. The company offers a comprehensive suite of services, including procurement, deployment, operation, replacement, and recycling of IT equipment such as laptops, desktops, servers, and network devices. Additionally, GlobalServe provides a range of IT services, including hardware support, data backup and recovery, staff augmentation, and consulting. Its diverse client base spans industries such as oil and gas, manufacturing, consumer products, quick service restaurants, and technology. With an additional office in London, GlobalServe continues to enhance its global reach and service offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.